Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease squamous cell carcinoma of head and neck
Comorbidity |squamous cell carcinoma
Sentences 200
PubMedID- 24393330 Nasopharyngeal carcinoma (npc) is an epstein barr virus (ebv) associated squamous cell carcinoma of the head and neck.
PubMedID- 20969746 squamous cell carcinoma of head and neck (hnscc), including the oral cavity, pharynx, and larynx, is the sixth most common cancer in the world [1].
PubMedID- 22402942 Similarly, the combination has minimal clinical activity in patients with advanced upper gastrointestinal cancers [25] and recurrent advanced squamous cell carcinoma of the head and neck [26].
PubMedID- 22681652 squamous cell carcinoma of the head and neck region are the most frequently diagnosed cancers among albinos in our environment.
PubMedID- 22723937 Therefore, this mirna has been found to be frequently silenced by methylation in several cancers including colorectal cancer [45], gastric cancer [46], uveal melanoma [47], oral cancer [48], glioblastoma multiforme [49] and squamous cell carcinoma of the head and neck [50], [51], and potentially acts as a tumor suppressor microrna in these tumors.
PubMedID- 21184685 The 91 investigated patients with histologically confirmed squamous cell carcinoma of the head and neck (scchn) comprised 15 women and 76 men.
PubMedID- 24386210 Nuclear nrf2 expression has been reported at different frequencies in other epithelial tumors, including squamous cell carcinoma of the head and neck [17], [18] and lung cancer.
PubMedID- 24116137 In addition, it correlated with poor prognosis in several hematopoietic malignancies [10,11], gastric cancer [12] and squamous cell carcinoma of the head and neck [13].
PubMedID- 22537712 The second study reported costs during the first 6 months after diagnoses for patients aged 35 and older with commercial insurance or medicare with advanced squamous cell carcinoma of the head and neck[5].
PubMedID- 24591744 In contrast, decreased cathepsin h expression has also been reported in squamous cell carcinoma of the head and neck[44].
PubMedID- 21776391 squamous cell carcinoma of the head and neck (hnscc) is a heterogeneous disease that includes tumors arising from the mucosal epithelial surface of the oral cavity, oropharynx, hypopharynx, and larynx.
PubMedID- 25029652 squamous cell carcinoma of the head and neck is one of the most common types of cancerworldwide, and the prevalence of heavy smoking is high in this group.
PubMedID- 20822525 N-cam expression has been reported in bile duct cancer [70], squamous cell carcinoma of head and neck [71], prostate cancer [72], and malignancies of the salivary gland [73].
PubMedID- 25395947 Previous studies have reported that serum pge-2 was elevated in squamous cell carcinoma of the head and neck [23, 24] and of the esophagus [25].
PubMedID- 21822357 Egfr mab therapies are effective for treating squamous cell carcinoma of the head and neck and are also being evaluated in other hpv-associated tumors [29].
PubMedID- 23976970 Hb: hospital-based; pb: population-based; pcr-rflp: polymerase chain reaction-restricted fligment length polymorphism; hwe: hardy-winberg equibrilium; na: not available; nc: nasopharyngeal carcinoma; ec: esophageal carcinoma; lc: lung cancer; bc: breast cancer; scchn: squamous cell carcinoma of the head and neck; lscc: laryngeal squamous cell carcinoma; hcc: hepatocellular carcinoma; a: mean + standard devation; † the study by lu j [18] was treated as two studies, lu ja: test set, lu jb: validation set;‡ in the study by naidu r [20], each population was considered as a study.
PubMedID- 24364026 squamous cell carcinoma of the head and neck (hnscc) is the sixth most-common cancer in the developed world [1, 2] and represents a therapeutically-challenging, behaviourally-heterogenous category of disease.
PubMedID- 20565895 squamous cell carcinoma of the head and neck (scchn) is considered the sixth most common cancer in the world [1].
PubMedID- 25625305 However, when compared hpv-positive with hpv-negative squamous cell carcinoma of the head and neck cell lines, this mirna was downregulated in the presence of hpv-16 dna [35].
PubMedID- 22546534 [22] reported a study which included 208 patients with advanced squamous cell carcinoma of the head and neck following co2 laser resection, patients were given postoperative radiotherapy.
PubMedID- 24616882 Imrt, intensity modulated radiotherapy; nsclc, non-small cell lung cancer; rt, radiotherapy; msi, microsatellite instability; crpc, castrate resistant prostate cancer; sclc, small cell lung cancer; gbm, glioblastoma multiforme; dpg, diffuse pontine glioma; hnscc, squamous cell carcinoma of the head and neck; 5-fu, 5-fluorouracil; pld, pegylated liposomal doxorubicin.
PubMedID- 24421989 It is a well established oncogene that has beendemonstrated to promote cell proliferation and suppresses apoptosis identified invarious cancers including squamous cell carcinoma of the head and neck/oral cavity.once it was realized that microrna-21 transfected cells had a growth advantage overnormal controls the potential targets were investigated.
PubMedID- 22674532 We investigated risk factors for superficial hnscc in patients with esophageal squamous cell carcinoma (escc).
PubMedID- 22295201 In a phase i study on 27 patients with pretreated (2nd- or 3rd- line treatment) stage iv cancer (19 pancreatic carcinoma, 6 renal cell carcinoma, 1 gastric cancer, and 1 squamous cell carcinoma of the head and neck scchn), lipoplatin dose was escalated from 25 to 125 mg/m2, and it was administered as an 8-hour infusion diluted in 1 l 5% dextrose, repeated every 2 weeks without need for pre or posthydration.
PubMedID- 21660277 squamous cell carcinoma of the head and neck is diagnosed annually in approximately 40,000 patients in the united states [1].
PubMedID- 24599075 squamous cell carcinoma of the head and neck (scchn) is the 6th most common malignancy worldwide [8] with a worldwide incidence of at least 500,000 and will be diagnosed in approximately 45,000 new patients in the united states this year [9].
PubMedID- 21461387 This paper examines the diagnosis, pathology, clinical course, and treatment options for cutaneous squamous cell carcinoma of the head and neck.
PubMedID- 21085979 squamous cell carcinoma of the head and neck (scchn) has been shown to express a number of chemokines, and their receptors, which may e.g., promote chemotherapy resistance (muller et al.
PubMedID- 24587773 squamous cell carcinoma of the head and neck (hnscc) is primarily a disease of older adults, occurring most frequently in patients older than age 45. epidemiological studies over last 20 years have shown a steady rise in the incidence of these cancers in younger adults (age 18–45 years), especially in cancers of the oropharynx and oral cavity.1,2 the predilection for these particular subsites vs. other sites such as the larynx or the hypopharynx remains unclear.
PubMedID- 22913768 We also note, however, that this code has been employed in several single technology appraisals (stas) and evidence review group’s (erg) reports to cost chemotherapy-related febrile neutropenia among adults with her2-negative metastatic breast cancer, adults with chronic lymphocytic leukemia, adults with metastatic prostate cancer, and adults with squamous cell carcinoma of the head and neck, respectively [15-18].
PubMedID- 24358243 Used the same uv-vis diffuse reflectance spectroscopy system in an in vivo clinical study in which 21 patients with mucosal squamous cell carcinoma of the head and neck were evaluated [34].
PubMedID- 24457040 We conducted a comprehensive search in pubmed, cochrane library and chinese biomedical literature database (cbm), covering all articles published up to oct 31, 2013, using the following terms: “rad51” and “polymorphism” and “(squamous cell carcinoma of the head and neck) or (colorectal cancer) or (ovarian cancer) or (acute leukaemia)”.
PubMedID- 24516537 squamous cell carcinoma of the head and neck (scchn), including the oral cavity, nasopharynx, hypopharynx, larynx and tongue, is the 5th most common cancer worldwide and represents 4% of all diagnosed neoplasms [1].
PubMedID- 25980577 Also, a patient with squamous cell carcinoma of head and neck with wt pik3ca and an egfr exon 21 mutation (h835l) in an initial resected tumor was found to have a pik3ca e545k mutation (0.05%) in cfdna collected after progressive disease following 3 months of cetuximab, carboplatin and paclitaxel treatment.
PubMedID- 22472064 Long-term disease control for patients with advanced squamous cell carcinoma of the head and neck (scchn) is still challenging.
PubMedID- 22704532 All patients had a squamous cell carcinoma of the head and neck, with 19 oropharyngeal tumors (66%), 6 laryngeal (21%), 3 nasopharynx (10%) and 1 oral cavity (3%).
PubMedID- 20587061 squamous cell carcinoma of the head and neck (hnscc) has an estimated incidence of 35,310 new cases in 2008 in the united states, with an expected 7590 deaths due to these cancers.
PubMedID- PMC4466650 squamous cell carcinoma of the head and neck (hnscc) is the sixth most prevalent cancer in the world [1].
PubMedID- 25927305 Cyp2c19 pm status interacts significantly with environmental risk factors in modifying susceptibility to squamous cell carcinoma of the head and neck [30].
PubMedID- 25874882 It was reported that krt17 could be a tumor marker in squamous cell carcinoma of head and neck and breast cancers [36,37].
PubMedID- 20713318 In our unpublished experience on 131 patients followed up for squamous cell carcinoma of the head and neck, the 40 recurrences appeared bright on b-1000 images, the mean adc value of recurrences was comparable with that of primary tumors (0.97 × 10−3 mm2/s vs 0.89 × 10−3 mm2/s, p = ns); conversely, mature scar lesions invariably appeared dark as background normal tissues on b1000 images (fig.
PubMedID- 24013949 Cancer types were classified as breast cancer, squamous cancer (squamous cell carcinoma of head and neck, and laryngeal squamous cell carcinoma), and other cancers (nasopharyngeal carcinoma, esophageal carcinoma, lung cancer, and hepatocellular carcinoma).
PubMedID- 24514166 Hspb5 was also reported to be downregulated in anaplastic thyroid carcinomas [66], nasopharyngeal carcinomas [67], cutaneous squamous cell carcinoma of the head and neck with clinical perineural invasion [68], oral cancer [69,70] as well as human ovarian cancer [71] and testicular tumors [63].
PubMedID- 25993495 For some cancers in particular (e.g., brain tumors such as glioblastoma multiforme and squamous cell carcinoma of the head and neck – scchn) it is a cause of severe morbidity and can be life-threatening even in the absence of distant metastases.
PubMedID- 25909285 In patients with recurrent or metastatic squamous cell carcinoma of the head and neck, stable disease with minor tumor shrinkage was found in half of patients received foretinib treatment and a combinational therapy with targeted agents or cytotixic chemotherapy was suggested [30].
PubMedID- 20335368 For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (scchn), platinum has been an integral part of palliative care for about the past 30 years.
PubMedID- 22408457 The us nih repository for clinical trials reports some trials involving epigenetic-based drugs in head and neck cancer treatment: azacitidine and cisplatin have been tested in combined chemotherapy in advanced, recurrent and metastatic squamous cell carcinoma of head and neck but no data are available to date about the outcome of the study [154].
PubMedID- 24603722 In our meta-analysis, the association between rs560191 polymorphism and other cancer types including cervical cancer, breast cancer and squamous cell carcinoma of the head and neck was also analyzed.
PubMedID- 24130817 Owing to this characteristic histology and the abundant lymphatic network in nasopharynx, npc exhibits greater regional and distant metastasis than other squamous cell carcinoma of head and neck (scchn).
PubMedID- 24495306 Metalloproteinases are particular important in oral cancer progression, and squamous cell carcinoma of head and neck has been classified as the fifth most common type of cancer in the world [9].

Page: 1 2 3 4